Article by Sam Riches, Growth Op There are many arguments for legalizing cannabis that are not rooted in dollars and cents. The disproportionate enforcement of cannabis laws, for example. Or the failures of prohibition. Or the potential for improved access to medical cannabis. Still, one of the oft-repeated arguments for legalization is the potential tax revenue that could be generated. ...

Article by Alan Brochstein, New Cannabis Ventures Statistics Canada released August retail sales for the country this morning, with sequential growth slowing from last month’s 15% gain, as overall cannabis sales grew 5% sequentially to C$244.9 million, up 94% from a year ago. The report detailed how Ontario, which grew 11% to C$66.9 million, drove the sales, as other major provinces increased ...

Article by Marijuana Business Daily Toronto-based cannabis producer The Flowr Corp. entered into a definitive agreement to acquire Terrace Global, a Canadian company focused on the development of international marijuana assets. The all-share transaction, expected to close by the end of the year, is worth about 63 million Canadian dollars ($48 million), Flowr said in a news release. Flowr CEO ...

Article by Kalina Laframboise, Global News Montreal police carried out raids at 17 homes and seized more than 1,000 marijuana plants in connection with the dismantling of an allegedly illegal cannabis network. The police force said in a statement the searches took place in Montreal, Laval and Saint-Lazare on Tuesday morning. The alleged network controlled several places of production and used a ...

Article by Jelena Martinovic, Benzinga Canada cannabis sales increased 94% over the year and 6% sequentially to CA$244.9 million in August. According to Statistics Canada, the growth can be attributed to the expansion of the retail footprint across provinces, including British Columbia and especially Ontario. Ontario sales contributed with CA$66.9 million in sales, which accounted for 11%, compared to 2-5% other ...

Article by Carly Fisher, Green Market Report At a time when it seems like no one can see eye-to-eye on anything, there is one undeniable fact that most can agree on: something needs to change. Industry leaders are hoping that 2021 will be the turnaround after a monumentally tragic year where the lingering effects of COVID-19 changed how business was ...

Article by Sarah Leamon, Georgia Straight It’s been two years since Bill C-46 became law, overhauling impaired-driving rules nationwide. Although Bill C-46 embodied a number of significant amendments to Criminal Code impaired-driving offences and other crimes, it did a couple of key things. For starters, it created specific offences for cannabis-impaired driving the first time. Secondly, it did away with the reasonable grounds to ...

Article by Justin Young, Deep Dive Last week Raymond James said in a note to investors, “Canadian Cannabis Stock Selloff Overdone | Fundamentals Driving Divergence Between Strong & Weak Operators.” Rahul Sarugaser, Raymond James’ analyst, calls the bottom in the Canadian Cannabis sector as he explains, “fundamentals are improving across the Canadian cannabis sector.” The analyst believes that there will ...

Article by Stock Day Media MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce its wholly-owned subsidiary, MediPharm Labs Inc., has initiated a clinical trial to research and evaluate the effectiveness of MediPharm Labs’ proprietary cannabis-derived medical products ...

Article by Sam Riches, Growth Op One of the more puzzling decisions made by the Canadian cannabis industry has been the choice to abandon legacy strain names in favour of new commercial names with zero meaning or resonance to consumers. This had led to some consumers compiling their own databases to try and keep track of cannabis lineage. But according to ...